Earnings History Data for Insmed Incorporated (INSM) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.

Insmed Incorporated

Insmed is a biopharmaceutical company engaged in the development and commercialization of ARIKAYCE, or liposomal amikacin for inhalation, for at least two identified orphan patient populations: patients with nontuberculous mycobacteria (NTM) lung infections and cystic fibrosis (CF) patients with Pseudomonas aeruginosa lung infections. Insmed is also focused on the development of INS1009, the company's inhaled treprostinil prodrug for the treatment of pulmonary arterial hypertension (PAH), a chronic, life-threatening disorder characterized by abnormally high blood pressure in the arteries between the heart and lungs.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
31-10-2024 PM INSM Insmed Incorporated 12,190 -1.27 -1.19 -1.10 Insmed GAAP EPS of -$1.27 misses by $0.06, revenue of $93.43M beats by $0.26M
[10/31/2024 7:08 AM]		 67.52 -2.78 
(-3.95%)		 69.00 -1.30 
(-1.84%)		 21.92 - 80.53 1,810,572 1,000,000 71,767
08-08-2024 PM INSM Insmed Incorporated 10,800 -1.94 -1.22 -1.78 Insmed GAAP EPS of -$1.94 misses by $0.75, revenue of $90.34M beats by $2.56M
[8/8/2024 7:13 AM]		 71.54 0.55 
(0.77%)		 69.00 -1.99 
(-2.80%)		 21.21 - 78.87 1,308,816 1,600,000 18,790
09-05-2024 PM INSM Insmed Incorporated 3,870 -1.06 -1.21 -1.17 Insmed reports mixed Q1 results; reaffirms FY24 outlook
[5/9/2024 7:47 AM]		 26.41 0.41 
(1.58%)		 27.30 1.30 
(5.00%)		 18.08 - 32.00 2,088,882 1,450,000 711
22-02-2024 PM INSM Insmed Incorporated 4,220 -1.28 -1.13 -1.20 Insmed GAAP EPS of -$1.28 misses by $0.13, revenue of $83.69M beats by $1.08M
[2/22/2024 7:19 AM]		 27.13 -1.11 
(-3.93%)		 27.71 -0.53 
(-1.88%)		 16.04 - 32.00 2,833,742 1,860,000 547
26-10-2023 PM INSM Insmed Incorporated 3,600 -1.10 -1.04 -1.09 Insmed Non-GAAP EPS of -$1.11 in-line, revenue of $79.07M misses by $0.25M
[10/26/2023 7:33 AM]		 25.55 0.10 
(0.39%)		 25.80 0.35 
(1.38%)		 16.04 - 27.59 1,089,403 1,310,000 722
03-08-2023 PM INSM Insmed Incorporated 3,020 -1.78 -1.10 -0.80 Insmed beats Q2 topline, raises FY guidance
[8/3/2023 7:39 AM]		 22.15 0.38 
(1.75%)		 22.15 0.0 
(0.00%)		 16.04 - 28.94 1,886,399 1,180,000 327,719
04-05-2023 PM 7:30 AM ET
(May 4)		 INSM Insmed Incorporated 2,630 -1.17 -1.08 -0.80 Insmed GAAP EPS of -$1.17 misses by $0.05, revenue of $65.21M beats by $1.28M
[5/4/2023 7:40 AM]		 19.54 -0.26 
(-1.31%)		 0.0 0.0 
(0.00%)		 16.04 - 28.94 934,335 1,270,000 0
23-02-2023 PM 7:30 AM ET
(Feb 23)		 INSM Insmed Incorporated 2,790 -1.20 -0.99 -0.95 Insmed reports Q4 earnings miss; reaffirms FY23 outlook
[2/23/2023 7:33 AM]		 20.39 -0.50 
(-2.39%)		 0.0 0.0 
(0.00%)		 16.41 - 28.94 1,218,573 1,260,000 0
27-10-2022 PM 7:30 AM ET
(Oct 27)		 INSM Insmed, Inc. 2,050 -1.09 -0.89 -0.96 Insmed GAAP EPS of -$1.09 misses by $0.20, revenue of $67.7M beats by $0.94M
[10/27/2022 7:34 AM]		 16.95 -0.76 
(-4.29%)		 17.50 -0.21 
(-1.19%)		 16.41 - 34.44 2,197,228 2,440,000 12,691
04-08-2022 PM 7:30 AM ET
(Aug 4)		 INSM Insmed, Inc. 2,670 -0.80 -0.89 -0.94 Insmed GAAP EPS of -$0.80 beats by $0.09, revenue of $65.2M beats by $6.28M
[8/4/2022 7:45 AM]		 25.04 3.28 
(15.07%)		 3.92 -0.40 
(-9.26%)		 16.41 - 34.44 2,147,628 960,000 51,552
05-05-2022 PM 7:00 AM ET
(May 5)		 INSM Insmed, Inc. 2,670 -0.80 -0.91 -0.89 Insmed GAAP EPS of -$0.80 beats by $0.10, revenue of $53.1M misses by $0.26M
[5/5/2022 7:39 AM]		 23.00 0.16 
(0.70%)		 23.49 0.65 
(2.85%)		 20.02 - 34.44 2,372,235 1,000,000 958
17-02-2022 PM 7:30 AM ET
(Feb 17)		 INSM Insmed, Inc. 2,720 -0.95 -0.89 1.00 Insmed GAAP EPS of -$0.95 misses by $0.05, revenue of $56.12M beats by $5.28M
[2/17/2022 7:13 AM]		 23.56 -0.44 
(-1.83%)		 24.17 0.17 
(0.71%)		 20.02 - 43.30 1,934,832 940,000 578
28-10-2021 PM 7:30 AM ET
(Oct 28)		 INSM Insmed, Inc. 3,100 -0.96 -0.83 -0.63 Insmed EPS misses by $0.10, misses on revenue
[10/28/2021 7:33 AM]		 29.65 3.25 
(12.31%)		 27.93 1.53 
(5.80%)		 22.00 - 45.44 2,508,342 880,000 420
05-08-2021 PM 7:30 AM ET
(Aug 5)		 INSM Insmed, Inc. 2,760 -0.94 -0.96 -0.64 Insmed EPS misses by $0.22, beats on revenue
[8/5/2021 7:34 AM]		 25.26 0.49 
(1.98%)		 24.77 0.0 
(0.00%)		 23.16 - 45.44 751,132 850,000 3,093
06-05-2021 PM 7:30 AM ET
(May 6)		 INSM Insmed, Inc. 3,230 -0.89 -0.91 -0.74 Insmed EPS misses by $0.01, misses on revenue
[5/6/2021 7:33 AM]		 32.50 1.98 
(6.49%)		 32.50 0.0 
(0.00%)		 22.65 - 45.44 1,204,026 740,000 19,701
25-02-2021 PM 7:30 AM ET
(Feb 25)		 INSM Insmed, Inc. 4,000 -1.00 -0.67 -0.59 Insmed EPS misses by $0.29, revenue in-line
[2/25/2021 7:34 AM]		 37.20 -2.83 
(-7.07%)		 40.03 0.0 
(0.00%)		 12.09 - 45.44 1,200,194 686,513 123,215
29-10-2020 PM 7:30 AM ET
(Oct 29)		 INSM Insmed, Inc. 3,680 -0.63 -0.59 -0.68 Insmed EPS misses by $0.04, misses on revenue
[10/29/2020 7:35 AM]		 31.67 -3.52 
(-10.02%)		 35.20 0.0 
(0.00%)		 12.09 - 39.39 1,892,576 732,403 66,320
06-08-2020 PM 7:30 AM ET
(Aug 6)		 INSM Insmed, Inc. 2,740 -0.64 -0.58 -0.81 Insmed EPS misses by $0.05, beats on revenue
[8/6/2020 7:37 AM]		 27.67 0.89 
(3.32%)		 28.50 1.72 
(6.42%)		 12.09 - 34.94 836,663 515,593 1,294